- Home
- ADCT vs AMPX Comparison
ADCT vs AMPX Comparison
Compare ADCT & AMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADCT
- AMPX
- Stock Information
- Founded
- ADCT 2011
- AMPX 2008
- Country
- ADCT Switzerland
- AMPX United States
- Employees
- ADCT N/A
- AMPX N/A
- Industry
- ADCT Biotechnology: Pharmaceutical Preparations
- AMPX Industrial Machinery/Components
- Sector
- ADCT Health Care
- AMPX Miscellaneous
- Exchange
- ADCT Nasdaq
- AMPX Nasdaq
- Market Cap
- ADCT 241.0M
- AMPX 261.6M
- IPO Year
- ADCT 2020
- AMPX N/A
- Fundamental
- Price
- ADCT $2.78
- AMPX $3.84
- Analyst Decision
- ADCT Strong Buy
- AMPX Strong Buy
- Analyst Count
- ADCT 6
- AMPX 7
- Target Price
- ADCT $7.80
- AMPX $8.71
- AVG Volume (30 Days)
- ADCT 937.9K
- AMPX 4.5M
- Earning Date
- ADCT 08-05-2025
- AMPX 08-07-2025
- Dividend Yield
- ADCT N/A
- AMPX N/A
- EPS Growth
- ADCT N/A
- AMPX N/A
- EPS
- ADCT N/A
- AMPX N/A
- Revenue
- ADCT $75,817,000.00
- AMPX $33,115,000.00
- Revenue This Year
- ADCT $10.65
- AMPX $167.22
- Revenue Next Year
- ADCT $15.05
- AMPX $208.02
- P/E Ratio
- ADCT N/A
- AMPX N/A
- Revenue Growth
- ADCT 10.49
- AMPX 209.20
- 52 Week Low
- ADCT $1.05
- AMPX $0.61
- 52 Week High
- ADCT $4.13
- AMPX $4.27
- Technical
- Relative Strength Index (RSI)
- ADCT 47.62
- AMPX 66.95
- Support Level
- ADCT $3.21
- AMPX $2.55
- Resistance Level
- ADCT $3.97
- AMPX $4.27
- Average True Range (ATR)
- ADCT 0.38
- AMPX 0.27
- MACD
- ADCT -0.12
- AMPX 0.08
- Stochastic Oscillator
- ADCT 3.43
- AMPX 75.00
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
About AMPX Amprius Technologies Inc.
Amprius Technologies Inc is engaged in the production of silicon anodes for high-energy-density lithium-ion batteries. The company develops, manufactures and markets lithium-ion batteries for mobility applications, including the aviation, electric vehicle (EV) and light electric vehicle (LEV) industries. The company's batteries are used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites.